THE CENTER FOR VIRAL HEPATITIS INC (EIN 471863590) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

CHUL S HYUN MD PHD

Phone

8456611477

Tax Period

2020-01-01 to 2020-12-31

Mission

THE GENERAL PURPOSES OF THE CENTER FOR VIRAL HEPATITIS INC ARE: (1)TO RAISE AWARENESS OF VIRAL HEPATITIS B AND C ("HEPATITIS") AND THEIR COMPLICATIONS IN COMMUNITIES LOCALLY, NATIONALLY, AND GLOBALLY, (2)TO PROVIDE PATIENTS AFFLICTED WITH HEPATITIS WITH SUPPORT AND TO LINK THEM WITH CLINICAL CARE, ESPECIALLY FOR THOSE THAT ARE ECONOMICALLY DISADVANTAGED, (3)TO SUPPORT CLINICAL RESEARCH AND PROVIDE PATIENTS ACCESS TO THE FRUITS OF SUCH RESEARCH, (4)TO REDUCE THE IMPACT OF HEPATITIS INFECTIONS BY SLOWING PROGRESSION AND COMPLICATIONS ARISING FROM HEPATITIS, THEREBY REDUCING MORBIDITY AND MORTALITY ASSOCIATED WITH HEPATITIS, AND (5)TO SUPPORT COLLABORATIVE ACTIVITIES BETWEEN BIOPHARMACEUTICAL COMPANIES AND HEPATITIS PATIENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $0

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $2,421

Other Expenses $2,421

TOTAL EXPENSES $2,421

Year-over-Year Comparison

	2020	2019	Change
Revenue	N/A	N/A	N/A
Expenses	$2,421	$94,869	-1.0%
Net Income	N/A	$-94,869	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CAROL CHO MD	SECRETARY	1.00	Officer Director	$0	$0	$0
KYUNG R LEE MD	TREASURER	1.00	Officer Director	$0	$0	$0
CHUL S HYUN MD PHD	PRESIDENT	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	No data	$2,421	$221	No data
2019	No data	$94,869	$2,642	No data
2018	$150,000	$115,636	$97,511	$34,364

THE CENTER FOR VIRAL HEPATITIS INC